Bronchenolo Sedativo Fluidificante 20 Pastiglie

ACTIVE INGREDIENTS

Bronchenolo Sedativo-e Fluidificante - 100 ml of the syrup contain
Bronchenolo Sedativo-e Fluidificante – 100 ml of the syrup contain

Bronchenolo Sedativo-e Fluidificante – 100 ml of the syrup contain: § active ingredients: dextromethorphan hydrobromide 0.15 g and guaifenesina 1.00 g; excipients with effects known: sucrose, propyl-and methyl-para-hydroxybenzoic, ethyl alcohol. One tablet contains: § active ingredients: dextromethorphan hydrobromide 7.5 mg and guaifenesina 55 mg; excipients with effects known: sucrose, aspartame. See section 6.1 for a complete list of excipients.

Excipients

BRONCHENOLO SEDATIVE AND DEPRESSIVE Syrup 100 ml syrup contains: pine essential oil; citric acid monohydrate; alcohol; glycerol; sucrose; orange sweet essence; propyl para-hydroxybenzoic; methyl para-hydroxybenzoic; sodium saccharin; purified water. BRONCHENOLO Soothing and Calming Mint Flavor Pills One 2.3 g tablet BRONCHENOLO Soothing and Calming Mint Flavor contains: pine essential oil; magnesium trisilicate; aspartame; magnesium stearate; sucrose; mint flavoring.

THERAPEUTIC INDICATIONS

Symptomatic treatment of cough.

CONTRAINDICATIONS

Hypersensitivity to the active substance or any of the excipients listed in paragraph 6.1. Children under the age of 6 years. Patients who are taking or have taken within the last two weeks antidepressants, monoamine oxidase inhibitors (MAOIs) (see section 4.5). Patients with or at risk of respiratory failure (e.g., patients with chronic obstructive airway disease or pneumonia, patients with asthma attacks, during, or with exacerbation of asthma).

DOSAGE

Dosage Syrup for Adults (including elderly): 2 teaspoons (10 ml) 2-4 times a day, up to 8 teaspoons (40 ml) a day.
Pediatric population Children over 12 years of age: 2 teaspoons (10 ml) 2-4 times daily, up to 8 teaspoons (40 ml) per day. Children 6 to 12 years of age: 1 teaspoon (5 ml) 3-4 times a day, up to a maximum of 4 teaspoons (20 ml) per day. Administer every 4 to 6 hours as needed. Caps Adults (including the elderly): 3 to 6 tablets per day, up to 6 tablets per day to be mashed in the mouth.
Pediatric population Children over 12 years of age: 3 to 6 tablets per day mashed by mouth, up to 6 tablets per day. Children 6 to 12 years of age: 2 to 3 lozenges per day to melt in the mouth, up to 3 lozenges per day.Administer every 4 to 6 hours as needed. Method of administration To be administered orally only. Do not exceed the recommended doses.

WARNINGS

In the following cases, BRONCHENOLO EFFECTIVE AND TREATMENT should only be used after a thorough medical examination: – chronic cough or a prolonged cough like that seen with asthma or pulmonary emphysema; – severe hepatic impairment; – severe renal impairment; – concurrent use of antidepressants, selective serotonin reuptake inhibitors or tricyclic antidepressants (see section 4.5). The patient should be informed, consult your physician if the cough does not go away or if it is accompanied by high fever, rash, or persistent headaches. Do not exceed the maximum recommended dose or frequency of administration. After 5 to 7 days of treatment without significant results, clinical evaluation is required. Concomitant use of other cough and cold medications should be avoided. The concomitant use of alcohol during therapy with BRONCHENOLO SUSTAINED and TECUCHED should be avoided. Information on excipients with effects are known BRONCHENOLO Soothe and Dissolve syrup contains: § sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase deficiency should not take this medication; § ethyl alcohol. This medication contains 5.94% ethanol, which is up to 470 mg per dose, the equivalent of 11.9 ml of beer and 4.9 ml of wine. This can be harmful to alcoholics. Keep in mind, in women during pregnancy or lactation, in children and in high-risk groups like people with liver disease or epilepsy; § propyl and methyl-para-hydroxybenzoic, which can cause allergic reactions (possibly delayed). BRONCHENOLO SUSTAINABLE AND TREATMENT Pads taste peppermint contains: § sucrose. Patients with rare inherited problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase deficiency should not take this medication; § aspartame. This medication contains a source of phenylalanine. May be harmful if he/she suffers from phenylketonuria.

After taking the pills, you need a good rest on comfortable furniture, which can be bought on this site: